These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9456169)

  • 61. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
    Ridker PM
    Vasc Med; 1998; 3(1):67-73. PubMed ID: 9666536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Venous thrombosis in a replanted finger with underlying factor V Leiden mutation.
    Kenner L; Schwarzl F; Moshammer H; Haas F; Hoefler G; Pierer G
    Br J Plast Surg; 1998 Jan; 51(1):57-8. PubMed ID: 9577320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A case of ischemic colitis associated with factor V Leiden mutation: successful treatment with anticoagulation.
    Chin BW; Greenberg D; Wilson RB; Meredith CG
    Gastrointest Endosc; 2007 Aug; 66(2):416-8. PubMed ID: 17524402
    [No Abstract]   [Full Text] [Related]  

  • 65. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden.
    Robison NJ; Dawlabani N; Lastra CR; Dhall G
    Pediatr Blood Cancer; 2009 Jul; 52(7):867-9. PubMed ID: 19260108
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke.
    Lalouschek W; Suess E; Aull S; Schnider P; Uhl F; Zeiler K; Pabinger-Fasching I
    Stroke; 1995 Oct; 26(10):1963-4. PubMed ID: 7570761
    [No Abstract]   [Full Text] [Related]  

  • 67. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
    Weitz IC; Israel VK; Liebman HA
    Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.
    Ridker PM; Miletich JP; Hennekens CH; Buring JE
    JAMA; 1997 Apr 23-30; 277(16):1305-7. PubMed ID: 9109469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
    Van Rooden CJ; Rosendaal FR; Meinders AE; Van Oostayen JA; Van Der Meer FJ; Huisman MV
    Haematologica; 2004 Feb; 89(2):201-6. PubMed ID: 15003896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low prevalence of the factor V Leiden among patients with ischemic stroke.
    Sánchez J; Román J; de la Torre MJ; Velasco F; Torres A
    Haemostasis; 1997; 27(1):9-15. PubMed ID: 9097081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation.
    Berge E; Haug KB; Sandset EC; Haugbro KK; Turkovic M; Sandset PM
    Stroke; 2007 Mar; 38(3):1069-71. PubMed ID: 17290027
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study.
    Hamedani AG; Cole JW; Cheng Y; Sparks MJ; O'Connell JR; Stine OC; Wozniak MA; Stern BJ; Mitchell BD; Kittner SJ
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):419-23. PubMed ID: 22100829
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factor V Leiden mutation and the risk of thrombo-embolic disease in pregnancy: a case report.
    Schneider DJ; Steyn PS; Mansvelt EP
    Eur J Obstet Gynecol Reprod Biol; 2000 Aug; 91(2):197-8. PubMed ID: 10869795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Homozygous factor V Leiden mutation in a patient with traumatic leg ulceration.
    McLoone N; Lee B; Anderson J; McKenna K
    Clin Exp Dermatol; 2003 Nov; 28(6):608-9. PubMed ID: 14616826
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
    van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
    Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The role of resistance to C active protein (R-APC) in a pediatric stroke].
    Cardo E; Campistol J; Kirkham F
    Rev Neurol; 1997 Oct; 25(146):1589-91. PubMed ID: 9462989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.